Graduate student

Julien Roche-Prellezo holds a Master’s degree in Cancer Biology from the University of Montpellier, France. He completed a Master’s internship in the Pépin lab in 2024, where he investigated the roles of follistatin in ovarian cancer. In 2025, he returned as a PhD student to the Pépin, working under the guidance of Dr. Maëva Chauvin and in collaboration with Dr. Nathalie Bonnefoy’s team at the Institut de Recherche en Cancérologie de Montpellier (IRCM, France). He is currently  investigating the role of cancer-associated mesothelial cells (CAMCs) in ovarian cancer, with the aim of identifying novel therapeutic strategies to overcome tumor resistance.

Project: Investigating the role of cancer-associated mesothelial cells on the tumor immune microenvironment to overcome ovarian cancer resistance